You are here

bloodthinners

Bayer's patent for blood thinner Xarelto invalid, UK court rules

Reuters

Fri, 04/12/24 - 11:06 am

Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast

Fierce Biotech

Mon, 11/20/23 - 11:41 am

clinical trials

Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients

BioPharma Dive

Thu, 03/2/23 - 10:41 pm

Bristol Myers Squibb

clinical trials

Bayer begins key tests for closely watched blood thinner

BioPharma Dive

Wed, 02/8/23 - 11:01 pm

clinical trials

Anthos doubles down on its novel blood thinner

EP Vantage

Fri, 01/27/23 - 10:34 am

Factor XI inhibitor

Merck, seeking XI factor in race with Bayer, gets FDA fast-track tag for anticoagulant

Fierce Biotech

Tue, 08/23/22 - 10:32 am

end-stage renal disease

ESC 2022 preview – who’s got the XI factor?

EP Vantage

Tue, 08/23/22 - 10:23 am

Bristol Myers Squibb

CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback

Fierce Pharma

Fri, 06/24/22 - 10:42 am

Bristol Myers Squibb

Running behind Bristol Myers and J&J, Bayer inches forward in the next-gen blood thinner race

Endpoints

Mon, 04/4/22 - 10:56 am

clinical trials

Bristol Myers Squibb

Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?

Motley Fool

Sun, 12/5/21 - 10:49 pm

Bristol Myers Squibb

clinical trials

ACC 2021: J&J, Bayer pad case for Xarelto in post-surgery artery disease patients

Fierce Pharma

Sun, 05/16/21 - 11:32 pm

Pfizer, Bristol Myers' Eliquis flops in post-heart surgery patients, spurring an 'unexplained signal' in certain deaths

Endpoints

Sun, 05/16/21 - 11:23 pm

Bristol Myers Squibb

Blood Thinners Could Cut Risk Of Covid-19 Death In Hospital, Study Finds

Forbes

Fri, 02/12/21 - 11:05 am

AstraZeneca makes case for use of blood thinner Brilinta in stroke patients

Endpoints

Mon, 01/27/20 - 10:40 am

clinical trials

As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis

Endpoints

Thu, 12/26/19 - 01:18 pm

Bristol-Myers Squibb

ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe

Fierce Pharma

Mon, 09/2/19 - 12:17 pm

Bristol-Myers Squibb

European Society of Cardiology

Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement

Fierce Pharma

Wed, 06/19/19 - 10:57 pm

Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up

Fierce Pharma

Tue, 04/23/19 - 12:10 pm

Bristol-Myers Squibb

J&J snaps up key label expansion for Xarelto

Biopharma Dive

Mon, 10/15/18 - 12:10 pm

Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease

Pipeline Review

Sat, 08/25/18 - 09:40 pm

Pages